Tucker John H 4
4 · scPharmaceuticals Inc. · Filed Feb 1, 2022
Insider Transaction Report
Form 4
Tucker John H
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-01-31+249,000→ 249,000 totalExercise: $4.31Exp: 2032-01-31→ Common Stock (249,000 underlying)
Footnotes (1)
- [F1]The option shares vest over a four-year period, at a rate of 25% on the first anniversary of the grant date, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares are fully vested on the fourth anniversary of the grant date.